Tumor lysis syndrome is a potentially life-threatening condition that occurs when cancer cells release their contents into the bloodstream, often after chemotherapy, leading to metabolic abnormalities such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Prompt recognition and management are crucial to prevent acute kidney injury and other serious complications.